Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations August 31, 2017 BioTime Expands OpRegen Clinical Trial In Dry-AMD With Opening Of First U.S. Sites March 12, 2017 NeoTract, Inc.'s Minimally Invasive UroLift System For Enlarged Prostate Now Shown To Be Durable Through Five Years: Results From Pivotal L.I.F.T. Randomized Study Presented March 26, 2017
Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations August 31, 2017
NeoTract, Inc.'s Minimally Invasive UroLift System For Enlarged Prostate Now Shown To Be Durable Through Five Years: Results From Pivotal L.I.F.T. Randomized Study Presented March 26, 2017
